Руководство Европейского респираторного общества по диагностике и лечению лимфангиолейомиоматоза
С. Р. Джонсон,
Дж. Ф. Кордье,
К. . Лазор,
В. . Коттен,
У. . Костабель,
С. . Харари,
М. . Рено-Габер,
А. . Болер,
М. . Броне,
Х. . Поппер,
К. . Кингсвуд
https://doi.org/10.18093/0869-0189-2010-6-9-23
Аннотация
Источник: Johnson S.R., Cordier J.F., Lazor R. et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35: 14-26. В 2010 г. в Европейском респираторном журнале было опубликовано Руководство по диагностике и лечению лимфангиолейомиоматоза (ЛАМ). Это Руководство было подготовлено группой экспертов по инициативе Европейского респираторного общества (ЕРО).
Об авторах
С. Р. ДжонсонРоссия
Дж. Ф. Кордье
Россия
К. . Лазор
Россия
В. . Коттен
Россия
У. . Костабель
Россия
С. . Харари
Россия
М. . Рено-Габер
Россия
А. . Болер
Россия
М. . Броне
Россия
Х. . Поппер
Россия
К. . Кингсвуд
Россия
Список литературы
1. Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54: 254-264
2. Franz D.N., Brody A., Meyer C. et al. Mutational and radi� ographic analysis of pulmonary disease consistent with lym phangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am. J. Respir. Crit. Care Med. 2001; 164: 661-668
3. Urban T., Lazor R., Lacronique J. et al. Pulmonary lym� phangioleiomyomatosis. A study of 69 patients. Groupe d’Etudes et de Recherche sur les Maladies ‘‘Orphelines’’ Pulmonaires (GERM’’O’’P). Medicine (Baltimore) 1999; 78: 321-337
4. Johnson S.R., Tattersfield A.E. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am. J. Respir. Crit. Care Med. 1999; 160: 628-633
5. Aubry M.C., Myers J.L., Ryu J.H. et al. Pulmonary lymphangioleiomyomatosis in a man. Am. J. Respir. Crit. Care Med. 2000; 162: 749-752
6. Schiavina M., Di Scioscio V., Contini P. et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2007; 176: 96-98
7. Avila N.A., Kelly J.A., Chu S.C. et al. Lymphangioleio� myomatosis: abdominopelvic CT and US findings. Radio� logy 2000; 216: 147-153
8. Chu S.C., Horiba K., Usuki J. et al. Comprehensive evalua� tion of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041-1052
9. Moss J., DeCastro R., Patronas N.J. et al. Meningiomas in lymphangioleiomyomatosis. J. A. M. A. 2001; 286: 1879-1881
10. Johnson S.R., Tattersfield A.E. Clinical experience of lym� phangioleiomyomatosis in the UK. Thorax 2000; 55: 1052-1057
11. Ryu J.H., Doerr C.H., Fisher S.D. et al. Chylothorax in lym� phangioleiomyomatosis. Chest 2003; 123: 623-627
12. Goncharova E.A., Goncharov D.A., Eszterhas A. et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor sup� pressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 2002; 277: 30958-30967
13. Kenerson H., Folpe A.L., Takayama T.K. et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum. Pathol. 2007; 38: 1361-1371
14. Bissler J.J., McCormack F.X., Young L.R. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphan� gioleiomyomatosis. N. Engl. J. Med. 2008; 358: 140-151
15. Davies D.M., Johnson S.R., Tattersfield A.E. et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangi� oleiomyomatosis. N. Engl. J. Med. 2008; 358: 200-203
16. McCrory D.C., Lewis S.Z. Methodology and grading for pul� monary hypertension evidence review and guideline devel� opment. Chest 2004; 126 (Suppl. 1): 11S-13S
17. Baumann M.H., Strange C., Heffner J.E. et al. Management of spontaneous pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. Chest 2001; 119: 590-602
18. Ryu J.H., Moss J., Beck G.J. et al. The NHLBI lymphangi� oleiomyomatosis registry: characteristics of 230 patients at enrollment. Am. J. Respir. Crit. Care Med. 2006; 173: 105-111
19. Johnson S.R., Whale C.I., Hubbard R.B. et al. Survival and disease progression in UK patients with lymphangioleiomy� omatosis. Thorax 2004; 59: 800-803
20. Kitaichi M., Nishimura K., Itoh H. et al. Pulmonary lym� phangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am. J. Respir. Crit. Care Med. 1995; 151: 527-533
21. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Decline in lung function in patients with lymphangi� oleiomyomatosis treated with or without progesterone. Chest 2004; 126: 1867-1874
22. Carrington C.B., Cugell D.W., Gaensler E.A. et al. Lymphangioleiomyomatosis. Physiologic�pathologic�radi� ologic correlations. Am. Rev. Respir. Dis. 1977; 116: 977-995
23. Matsui K., Beasley M.B., Nelson W.K. et al. Prognostic sig� nificance of pulmonary lymphangioleiomyomatosis histo� logic score. Am. J. Surg. Pathol. 2001; 25: 479-484
24. Corrin B., Liebow A., Friedman P. Pulmonary lymphan� giomyomatosis. A review. Am. J. Pathol. 1975; 79: 348-382
25. Bonetti F., Chiodera P.L., Pea M. et al. Transbronchial biop� sy in lymphangiomyomatosis of the lung. HMB45 for diag� nosis. Am. J. Surg. Pathol. 1993; 17: 1092-1102
26. Matsui K., Takeda K., Yu Z.X. et al. Downregulation of estro� gen and progesterone receptors in the abnormal smooth mus� cle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am. J. Respir. Crit. Care Med. 2000; 161: 1002-1009
27. Glassberg M.K., Elliot S.J., Fritz J. et al. Activation of the estrogen receptor contributes to the progression of pul� monary lymphangioleiomyomatosis via MMP�induced cell invasiveness. J. Clin. Endocrinol. 2008; 93: 1625-1633
28. Zompatori M., Poletti V., Battista G. et al. Diffuse cystic lung disease in the adult patient. Radiol. Med. (Torino) 2000; 99: 12-21
29. Steagall W.K., Glasgow C.G., Hathaway O.M. et al. Genetic and morphologic determinants of pneumothorax in lym� phangioleiomyomatosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2007; 293: L800-L808
30. Lenoir S., Grenier P., Brauner M.W. et al. Pulmonary lym� phangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin�section CT findings. Radiology 1990; 175: 329-334
31. Muller N.L., Chiles C., Kullnig P. Pulmonary lymphan� giomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175: 335-339
32. Abbott G.F., RosadodeChristenson M.L., Frazier A.A. et al. From the archives of the AFIP: lymphangioleiomyomatosis: radiologicpathologic correlation. Radiographics 2005; 25: 803-828
33. Helenon O., Merran S., Paraf F. et al. Unusual fat�contain� ing tumors of the kidney: a diagnostic dilemma. Radiographics 1997; 17: 129-144
34. Roach E.S., Sparagana S.P. Diagnosis of tuberous sclerosis complex. J. Child Neurol. 2004; 19: 643-649
35. TaveiraDaSilva A.M., Hedin C., Stylianou M.P. et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2001; 164: 1072-1076
36. Taylor J.R., Ryu J., Colby T.V. et al. Lymphangio� leiomyomatosis. Clinical course in 32 patients. N. Engl. J. Med. 1990; 323: 1254-1260
37. Boehler A., Speich R., Russi E.W. et al. Lung transplantation for lymphangioleiomyomatosis. N. Engl. J. Med. 1996; 335: 1275-1280
38. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Maximal oxygen uptake and severity of disease in lymphan� gioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2003; 168: 1427-1431
39. Costello L.C., Hartman T.E., Ryu J.H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin. Proc. 2000; 75: 591-594
40. Moss J., Avila N.A., Barnes P.M. et al. Prevalence and clini� cal characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2001; 164: 669-671
41. Castro M., Shepherd C.W., Gomez M.R. et al. Pulmonary tuberous sclerosis. Chest 1995; 107: 189-195
42. Kim N.R., Chung M.P., Park C.K. et al. Pulmonary lym� phangioleiomyomatosis and multiple hepatic angiomy� olipomas in a man. Pathol. Int. 2003; 53: 231-235
43. Casper K.A., Donnelly L.F., Chen B. et al. Tuberous sclerosis complex: renal imaging findings. Radiology 2002; 225: 451-456
44. Ewalt D.H., Sheffield E., Sparagana S.P. et al. Renal lesion growth in children with tuberous sclerosis complex. J. Urol. (Baltimore) 1998; 160: 141-145
45. Weiner D.M., Ewalt D.H., Roach E.S. et al. The tuberous sclerosis complex: a comprehensive review. J. Am. Coll. Surg. 1998; 187: 548-561
46. L’Hostis H., Deminiere C., Ferriere J.M. et al. Renal angiomyolipoma: a clinicopathologic, immunohistochemi� cal, and follow�up study of 46 cases. Am. J. Surg. Pathol. 1999; 23: 1011-1020
47. Nelson C.P., Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J. Urol. (Baltimore) 2002; 168: 1315-1325
48. Steiner M.S., Goldman S.M., Fishman E.K. et al. The natu� ral history of renal angiomyolipoma. J. Urol. (Baltimore) 1993; 150: 1782-1786
49. Kennelly M.J., Grossman H.B., Cho K.J. Outcome analysis of 42 cases of renal angiomyolipoma. J. Urol. (Baltimore) 1994; 152: 1988-1991
50. Dickinson M., Ruckle H., Beaghler M. et al. Renal angiomy� olipoma: optimal treatment based on size and symptoms. Clin. Nephrol. 1998; 49: 281-286
51. Lazor R., Valeyre D., Lacronique J. et al. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangi� oleiomyomatosis. Respir. Med. 2004; 98: 536-541
52. Cohen M.M., PollockBarZiv S., Johnson S.R. Emerging clinical picture of lymphangioleiomyomatosis. Thorax 2005; 60: 875-879
53. Almoosa K.F., Ryu J.H., Mendez J. et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006; 129: 1274-1281
54. Fujimoto M., Ohara N., Sasaki H. et al. Pregnancy compli� cated with pulmonary lymphangioleiomyomatosis: case report. Clin. Exp. Obstetr. Gynecol. 2005; 32: 199-200
55. Brunelli A., Catalini G., Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int. J. Gynaecol. Obstetr. 1996; 52: 289-290
56. McLoughlin L., Thomas G., Hasan K. Pregnancy and lym� phangioleiomyomatosis: anaesthetic management. Int. J. Obstetr. Anesth. 2003; 12: 40-44
57. Yockey C.C., Riepe R.E., Ryan K. Pulmonary lymphangi� oleiomyomatosis complicated by pregnancy. Kans. Med. 1986; 87: 277-278, 293
58. Warren S.E., Lee D., Martin V. et al. Pulmonary lymphan� giomyomatosis causing bilateral pneumothorax during pregnancy. Ann. Thorac. Surg. 1000; 55: 998-1000
59. Cohen M.M., Freyer A.M., Johnson S.R. Pregnancy experi� ences among women with lymphangioleiomyomatosis. Respir. Med. 2009; 103: 766-772
60. Raft J., Lalot J.M., Meistelman C. et al. Renal angiomy� olipoma rupture during pregnancy. Gynecol. Obstetr. Fertil 2006; 34: 917-919
61. Storm D.W., Mowad J.J. Conservative management of a bleeding renal angiomyolipoma in pregnancy. Obstetr. and Gynecol. 2006; 107: 490-492
62. Morales J.P., Georganas M., Khan M.S. et al. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc. Intervent. Radiol. 2005; 28: 265-268
63. Mascarenhas R., McLaughlin P. Haemorrhage from angiomyolipoma of kidney during pregnancy - a diagnostic dilemma. Ir. Med. J. 2001; 94: 83-84
64. Yano S. Exacerbation of pulmonary lymphangioleiomy� omatosis by exogenous oestrogen used for infertility treat� ment. Thorax 2002; 57: 1085-1086
65. Shen A., Iseman M.D., Waldron J.A. et al. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estro� gens. Chest 1987; 91: 782-785
66. Wilson A.M., Slack H.L., Soosay S.A. et al. Lymphangioleio� myomatosis. A series of three case reports illustrating the link with high oestrogen states. Scott. Med. J. 2001; 46: 150-152
67. Oberstein E.M., Fleming L.E., GomezMarin O. et al. Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease. J. Women’s Hlth 2003; 12: 81-85
68. PollockBarZiv S., Cohen M.M., Downey G.P. et al. Air trav� el in women with lymphangioleiomyomatosis. Thorax 2007; 62: 176-180
69. Rehabilitation BTSSoCs�coP. BTS statement on pul� monary rehabilitation. Thorax 2001; 56: 827-834
70. Managing stable COPD. Thorax 2004; 59: (Suppl. 1), i39-i130
71. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Bone mineral density in lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2005; 171: 61-67
72. Adamson D., Heinrichs W.L., Raybin D.M. et al. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am. Rev. Respir. Dis. 1985; 132: 916-921
73. Anker N., Francis D., Viskum K. 2 cases of lymphangi� oleiomyomatosis treated by hormonal manipulation. Ugeskr. Laeg. 1993; 155: 2354-2356
74. Banner A.S., Carrington C.B., Emory W.B. et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N. Engl. J. Med. 1981; 305: 204-209
75. Itoi K., Kuwabara M., Okubo K. et al. A case of pulmonary lymphangiomyomatosis treated with bilateral oophorecto� my and methyl�progesterone�acetate. Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31: 1146-1150
76. Brock E.T., Votto J.J. Lymphangioleiomyomatosis: treat� ment with hormonal manipulation. N. Y. St. J. Med. 1986; 86: 533-536
77. Klein M., Krieger O., Ruckser R. et al. Treatment of lym� phangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen - a case report. Arch. Gynecol. Obstetr. 1992; 252: 99-102
78. Svendsen T.L., Viskum K., Hansborg N. et al. Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medrox� yprogesterone, oophorectomy and tamoxifen. Br. J. Dis. Chest 1984; 78: 264-271
79. Tomasian A., Greenberg M.S., Rumerman H. Tamoxifen for lymphangioleiomyomatosis. N. Engl. J. Med. 1982; 306: 745-746
80. de la Fuente J., Paramo C., Roman F. et al. Lymphangio� leiomyomatosis: unsuccessful treatment with luteinizing� hormone�releasing hormone analogues. Eur. J. Med. 1993; 2: 377-378
81. Desurmont S., Bauters C., Copin M.C. et al. Treatment of pulmonary lymphangioleiomyomatosis using a GnRH ago� nist. Rev. Mal. Respir. 1996; 13: 300-304
82. Rossi G.A., Balbi B., Oddera S. et al. Response to treatment with an analog of the luteinizing�hormone�releasing hor� mone in a patient with pulmonary lymphangioleiomy� omatosis. Am. Rev. Respir. Dis. 1991; 143: 174-176
83. Harari S., Cassandro R., Chiodini J. et al. Effect of a gonadotrophin�releasing hormone analogue on lung func� tion in lymphangioleiomyomatosis. Chest 2008; 133: 448-454
84. Detterbeck F.C., Egan T.M., Mill M.R. Lung transplantation after previous thoracic surgical procedures. Ann. Thorac. Surg. 1995; 60: 139-143
85. Pechet T.T., Meyers B.F., Guthrie T.J. et al. Lung transplan� tation for lymphangioleiomyomatosis. J. Heart Lung Transplant. 2004; 23: 301-308
86. Morimoto N., Hirasaki S., Kamei T. et al. Pulmonary lym� phangiomyomatosis (LAM) developing chylothorax. Intern. Med. 2000; 39: 738-741
87. Avila N.A., Dwyer A.J., Rabel A. et al. CT of pleural abnor� malities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. Am. J. Roentgenol. 2006; 186: 1007-1012
88. Druelle S., Aubry P., LeviValensi P. Pulmonary lymphan� giomyomatosis: a 3�year follow�up of medroxyprogesterone acetate therapy. Apropos of a case. Rev. Pneumol. Clin. 1995; 51: 284-287
89. Zanella A., Toppan P., Nitti D. et al. Pulmonary lymphangi� oleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medroxyproges� terone acetate). Tumori 1996; 82: 96-98
90. Woґjcik P., Otto T., Jagieііo R. et al. Use of pleuro�peri� toneal shunt in the treatment of chronic chylothorax. Pneumonol. Alergol. Pol. 1998; 66: 473-479
91. Calvo E., Amarillas L., Mateos M.A. et al. Lymphangioleio� myomatosis, chylous ascites, and diet. Dig. Dis. Sci. 1996; 41: 591-593
92. Hamlin J.A., Smith D.C., Taylor F.C. et al. Renal angiomy� olipomas: long�term follow�up of embolization for acute hemorrhage. Can. Assoc. Radiol. J. 1997; 48: 191-198
93. Williams J.M., Racadio J.M., Johnson N.D. et al. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am. J. Kidney Dis. 2006; 47: 95-102
94. Igarashi A., Masuyama T., Watanabe K. et al. Long�term result of the transcatheter arterial embolization for ruptured renal angiomyolipoma. Nippon Hinyokika Gakkai Zasshi 2002; 93: 702-706
95. Bender B., Yunis E. The pathology of tuberous sclerosis. Pathol. Annu. 1982; 17: 339-382
96. Yamakado K., Tanaka N., Nakagawa T. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002; 225: 78-82
97. Trulock E.P. Lung transplantation: special considerations and outcome in LAM. In: Moss J., ed. LAM and other dis� eases characterised by smooth muscle proliferation. New York: Marcel Dekker; 1999. 65-78
98. Pigula F.A., Griffith B.P., Zenati M.A. et al. Lung trans� plantation for respiratory failure resulting from systemic disease. Ann. Thorac. Surg. 1997; 64: 1630-1634
99. Kpodonu J., Massad M.G., Chaer R.A. et al. The US experi� ence with lung transplantation for pulmonary lymphangi� oleiomyomatosis. J. Heart Lung Transplant. 2005; 24: 1247-1253
100. Boehler A. Lung transplantation for cystic lung diseases: lymphangioleiomyomatosis, histiocytosis x, and sarcoido� sis. Semin. Respir. Crit. Care Med. 2001; 22: 509-516
101. Benden C., Rea F., Behr J. et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J. Heart Lung Transplant. 2009; 28: 1-7
102. ReynaudGaubert M., Mornex J.F., Mal H. et al. Lung trans� plantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008; 86: 515-520
103. Collins J., Muller N.L., Kazerooni E.A. et al. Lung trans� plantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology 1999; 210: 325-332
104. Nine J.S., Yousem S.A., Paradis I.L. et al. Lymphangio� leiomyomatosis: recurrence after lung transplantation. J. Heart Lung Transplant. 1994; 13: 714-719
105. Bittmann I., Rolf B., Amann G. et al. Recurrence of lym� phangioleiomyomatosis after single lung transplantation: New insights into pathogenesis. Hum. Pathol. 2003; 34: 95-98
106. Karbowniczek M., Astrinidis A., Balsara B.R. et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am. J. Respir. Crit. Care Med. 2003; 167: 976-982
107. Benden C., Boehler A., Faro A. Pediatric lung transplanta� tion: Literature review. Pediatr. Transplant. 2008; 12: 266-273
Рецензия
Для цитирования:
Джонсон С.Р., Кордье Д.Ф., Лазор К., Коттен В., Костабель У., Харари С., Рено-Габер М., Болер А., Броне М., Поппер Х., Кингсвуд К. Руководство Европейского респираторного общества по диагностике и лечению лимфангиолейомиоматоза. Пульмонология. 2010;(6):9-23. https://doi.org/10.18093/0869-0189-2010-6-9-23
Просмотров:
454
ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)
ISSN 2541-9617 (Online)
Послать статью по эл. почте 